No benefit with adjuvant sorafenib in intermediate-/high-risk RCCNovember 2, 2020Renal Cell CarcinomaGenitourinary Cancer
Real-world results with checkpoint inhibitors found inferior to trial resultsOctober 30, 2020ImmunotherapyLung CancerMelanomaHead & Neck/Thyroid CancersGenitourinary CancerGastroenterologyRenal Cell Carcinoma
Lower BP and better tumor control with drug combo?October 26, 2020ImmunotherapyLung CancerBreast CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersGastroenterology
Are oncologists ready to confront a second wave of COVID-19?October 21, 2020Practice ManagementBreast CancerCNS/Brain CancerCOVID-19 UpdatesGastroenterologyGenitourinary CancerGynecologic Cancer
Durable efficacy with MK-6482 in VHL-associated RCCOctober 12, 2020Renal Cell CarcinomaGenitourinary Cancer
Clinical factors and treatment tied to COVID-19 mortality in cancer patientsOctober 8, 2020Patient & Survivor CareCNS/Brain CancerCOVID-19 UpdatesGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
The scope of under- and overtreatment in older adults with cancerOctober 1, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Cancer disparities: One of the most pressing public health issuesSeptember 30, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Predicting complications of cytoreductive nephrectomy in metastatic RCCSeptember 25, 2020Renal Cell CarcinomaGenitourinary Cancer
Nivo-cabo combo joins advanced RCC treatment ranksSeptember 22, 2020Renal Cell CarcinomaGenitourinary Cancer
Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaLung CancerLeukemia, Myelodysplasia, Transplantation
COVID-19 prompts ‘democratization’ of cancer trialsSeptember 16, 2020COVID-19 UpdatesPatient & Survivor CareCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
The march of immunotherapy continues at ESMO 2020September 15, 2020ImmunotherapyGenitourinary CancerGastroenterologyLung CancerPatient & Survivor CareRenal Cell CarcinomaPractice Management
Hair dye and cancer study ‘offers some reassurance’September 4, 2020Breast CancerGynecologic CancerCNS/Brain CancerGastroenterologyGenitourinary CancerLeukemia, Myelodysplasia, TransplantationLung Cancer
VTE, sepsis risk increased among COVID-19 patients with cancerAugust 31, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
